ENTRY       D10798                      Drug
NAME        Copanlisib hydrochloride hydrate (JAN);
            Aliqopa (TN)
PRODUCT     ALIQOPA (Bayer HealthCare Pharmaceuticals)
FORMULA     C23H28N8O4. 2HCl. xH2O
CLASS       Antineoplastic
             DG03139  PI3K inhibitor
            Metabolizing enzyme substrate
             DG01891  CYP1A1 substrate
             DG01633  CYP3A/CYP3A4 substrate
REMARK      ATC code: L01EM02
            Chemical structure group: DG01926
            Product (DG01926): D10798<US>
EFFICACY    Antineoplastic, Phosphatidylinositol 3-kinase inhibitor
  DISEASE   Follicular lymphoma [DS:H01613]
TARGET      PIK3CA [HSA:5290] [KO:K00922]
            PIK3CD [HSA:5293] [KO:K00922]
  PATHWAY   hsa04151(5290+5293)  PI3K-Akt signaling pathway
            hsa05200(5290+5293)  Pathways in cancer
METABOLISM  Enzyme: CYP3A [HSA:1576 1577 1551]; CYP1A1 [HSA:1543]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01E PROTEIN KINASE INHIBITORS
                L01EM Phosphatidylinositol-3-kinase (Pi3K) inhibitors
                 L01EM02 Copanlisib
                  D10798  Copanlisib hydrochloride hydrate (JAN) &lt;US&gt;
            Drug groups [BR:br08330]
             Antineoplastic
              DG03139  PI3K inhibitor
               DG01926  Copanlisib
                D10798  Copanlisib hydrochloride hydrate
             Metabolizing enzyme substrate
              DG01891  CYP1A1 substrate
               DG01926  Copanlisib
                D10798  Copanlisib hydrochloride hydrate
              DG01633  CYP3A/CYP3A4 substrate
               DG01926  Copanlisib
                D10798  Copanlisib hydrochloride hydrate
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Transferases (EC2)
               Phosphotransferase
                PIK3CA
                 D10798  Copanlisib hydrochloride hydrate (JAN) &lt;US&gt;
                PIK3CD
                 D10798  Copanlisib hydrochloride hydrate (JAN) &lt;US&gt;
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D10798
            Drug groups [BR:br08330]
             Antineoplastic
              DG03139  PI3K inhibitor
               DG01926  Copanlisib
             Metabolizing enzyme substrate
              DG01891  CYP1A1 substrate
               DG01926  Copanlisib
              DG01633  CYP3A/CYP3A4 substrate
               DG01926  Copanlisib
DBLINKS     PubChem: 316933534
ATOM        38
            1   N5x N    19.5187  -15.1112
            2   C8y C    19.5187  -16.5104
            3   C8y C    20.7080  -17.2100
            4   C8y C    21.9672  -16.5104
            5   N4y N    21.9672  -15.1112
            6   C8y C    20.7080  -14.4116
            7   N2x N    23.2965  -16.9302
            8   C1x C    24.0660  -15.8108
            9   C1x C    23.2965  -14.6915
            10  C8y C    18.3294  -17.2100
            11  C8y C    18.3294  -18.6092
            12  C8x C    19.5187  -19.3088
            13  C8x C    20.7080  -18.6092
            14  O2a O    17.1400  -16.5104
            15  C1a C    15.8808  -17.2100
            16  O2a O    17.1400  -19.3088
            17  C1b C    15.8808  -18.6092
            18  C1b C    14.6915  -19.3088
            19  C1b C    13.5022  -18.6092
            20  N1y N    12.3128  -19.3088
            21  C1x C    11.1235  -18.6092
            22  C1x C     9.8643  -19.3088
            23  O2x O     9.8643  -20.7080
            24  C1x C    11.0536  -21.4076
            25  C1x C    12.3128  -20.7080
            26  N1b N    20.7080  -13.0124
            27  C5a C    19.5187  -12.3128
            28  C8y C    18.3294  -13.0124
            29  O5a O    19.5187  -10.9137
            30  C8x C    17.1400  -12.3128
            31  N5x N    15.8108  -13.0124
            32  C8y C    15.8108  -14.4116
            33  N5x N    17.0701  -15.1112
            34  C8x C    18.3294  -14.4116
            35  N1a N    14.6215  -15.1112
            36  X   Cl   27.4241  -15.1812
            37  X   Cl   27.4241  -17.1400
            38  O0  O    26.8800  -20.4400
BOND        39
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     5   6 1
            6     1   6 2
            7     4   7 2
            8     7   8 1
            9     8   9 1
            10    5   9 1
            11    2  10 2
            12   10  11 1
            13   11  12 2
            14   12  13 1
            15    3  13 2
            16   10  14 1
            17   14  15 1
            18   11  16 1
            19   16  17 1
            20   17  18 1
            21   18  19 1
            22   19  20 1
            23   20  21 1
            24   21  22 1
            25   22  23 1
            26   23  24 1
            27   24  25 1
            28   20  25 1
            29    6  26 1
            30   26  27 1
            31   27  28 1
            32   27  29 2
            33   28  30 2
            34   30  31 1
            35   31  32 2
            36   32  33 1
            37   33  34 2
            38   28  34 1
            39   32  35 1
BRACKET     1    24.7800  -21.2800   24.7800  -19.4600
            1    27.7200  -19.4600   27.7200  -21.2800
            1  x
  ORIGINAL  1   38
  REPEAT    1 
///
